Cargando…
Autophagy Modulators in Cancer: Focus on Cancer Treatment
Uncontrolled autophagy has been associated with the development and progression of various cancers that are resistant to cancer therapy. Therefore, many efforts to modulate uncontrolled autophagy as a cancer treatment have been attempted, from basic science to clinical trials. However, it remains di...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401266/ https://www.ncbi.nlm.nih.gov/pubmed/34440583 http://dx.doi.org/10.3390/life11080839 |
_version_ | 1783745510143688704 |
---|---|
author | Nam, Hye Jin |
author_facet | Nam, Hye Jin |
author_sort | Nam, Hye Jin |
collection | PubMed |
description | Uncontrolled autophagy has been associated with the development and progression of various cancers that are resistant to cancer therapy. Therefore, many efforts to modulate uncontrolled autophagy as a cancer treatment have been attempted, from basic science to clinical trials. However, it remains difficult to equally apply autophagy modulators to cancer therapy because autophagy is a double-edged sword in cancer: it can be tumor-suppressive or tumor-protective. Therefore, the precise mechanisms of autophagy modulators and their varied responsiveness to each cancer type should be addressed in detail. This study will describe the precise mechanisms of developing various autophagy modulators, their current therapeutic applications and future perspectives. |
format | Online Article Text |
id | pubmed-8401266 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84012662021-08-29 Autophagy Modulators in Cancer: Focus on Cancer Treatment Nam, Hye Jin Life (Basel) Review Uncontrolled autophagy has been associated with the development and progression of various cancers that are resistant to cancer therapy. Therefore, many efforts to modulate uncontrolled autophagy as a cancer treatment have been attempted, from basic science to clinical trials. However, it remains difficult to equally apply autophagy modulators to cancer therapy because autophagy is a double-edged sword in cancer: it can be tumor-suppressive or tumor-protective. Therefore, the precise mechanisms of autophagy modulators and their varied responsiveness to each cancer type should be addressed in detail. This study will describe the precise mechanisms of developing various autophagy modulators, their current therapeutic applications and future perspectives. MDPI 2021-08-17 /pmc/articles/PMC8401266/ /pubmed/34440583 http://dx.doi.org/10.3390/life11080839 Text en © 2021 by the author. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Nam, Hye Jin Autophagy Modulators in Cancer: Focus on Cancer Treatment |
title | Autophagy Modulators in Cancer: Focus on Cancer Treatment |
title_full | Autophagy Modulators in Cancer: Focus on Cancer Treatment |
title_fullStr | Autophagy Modulators in Cancer: Focus on Cancer Treatment |
title_full_unstemmed | Autophagy Modulators in Cancer: Focus on Cancer Treatment |
title_short | Autophagy Modulators in Cancer: Focus on Cancer Treatment |
title_sort | autophagy modulators in cancer: focus on cancer treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8401266/ https://www.ncbi.nlm.nih.gov/pubmed/34440583 http://dx.doi.org/10.3390/life11080839 |
work_keys_str_mv | AT namhyejin autophagymodulatorsincancerfocusoncancertreatment |